Kerendia: payments to doctors
Payments that named Kerendia as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $35.7M
- Providers
- 102,537
- Transactions
- 613,653
- Average per transaction
- $58
The per-transaction average — $58 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 102,537 providers the average total is $348, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Bayer | $35,676,486 | 99.9% |
| Bayer Puerto Rico Inc. | $41,248 | 0.1% |
| Bayer Healthcare LLC | $133 | 0.0% |